Candesartan cilexetil: an angiotensin II receptor blocker. - Wikidata - wikimedia - TriplyDB

Candesartan cilexetil: an angiotensin II receptor blocker.

Candesartan cilexetil: an angiotensin II receptor blocker.

http://www.wikidata.org/entity/Q33814549

about

Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.Efficient synthesis of boron-containing α-acyloxyamide analogs via microwave irradiation.

P2860

Q34543485-80238906-7F47-4FEE-A030-1A74099CCCC8 Q35925706-14D63CA8-854E-4E86-8A4B-AA1BE83CF633 Q39107032-C1B8638E-3E1E-4C95-9984-6BBEA3C9D08C

P2860

Candesartan cilexetil: an angiotensin II receptor blocker.

http://www.wikidata.org/entity/Q33814549

description

1999 nî lūn-bûn

@nan

1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Candesartan cilexetil: an angiotensin II receptor blocker.

@ast

Candesartan cilexetil: an angiotensin II receptor blocker.

@en

type

label

Candesartan cilexetil: an angiotensin II receptor blocker.

@ast

Candesartan cilexetil: an angiotensin II receptor blocker.

@en

prefLabel

Candesartan cilexetil: an angiotensin II receptor blocker.

@ast

Candesartan cilexetil: an angiotensin II receptor blocker.

@en

P1433

Q33814549-132A794D-B7C6-4FFE-9776-DCF4739C884E

P1476

Q33814549-7B04C22C-4315-499D-9398-E4DEFAA48FF6

P2093

Q33814549-1208E2D7-41F4-4E5C-95F8-65DBDBB5520C

Q33814549-A83DE042-65AB-4E16-A500-FEEA8103A4EC

Q33814549-CA9A5DFF-F9F7-43D8-BEDA-459A207E6F92

P2860

Q33814549-05847CC8-E9DD-4B08-9A19-F5E9C692569D

Q33814549-06F4A573-7AE1-45F6-B5E6-34330B6E6ED9

Q33814549-1948E527-8E14-410E-A776-15A797CC5442

Q33814549-2F4FF892-D3BC-4AAB-81CE-41BFCEB78CFA

Q33814549-40EC91AA-0377-462C-89F9-F6E68BC65FC0

Q33814549-5D7B52E6-CB85-4277-85DF-B8A14E842FCE

Q33814549-7206592F-4F54-40D0-9F4A-C8BFBC84B9CA

Q33814549-C27EF8E8-CDC7-4740-B76B-A6E44C49D9CA

P304

Q33814549-439995AF-B043-47D1-AD02-32A93837C79F

P31

Q33814549-2533E21B-8BE6-4AC2-B37C-8FFDF86C909E

P356

Q33814549-C11A19A1-AF36-4FA0-A8C9-937F2D991BAB

P407

Q33814549-118CD6C4-8A4B-4CE2-BB95-ADF44DA891E6

P433

Q33814549-95B716AB-9DE7-497D-AB07-4FBCC029DD07

P478

Q33814549-BB0E02F4-1275-4246-B1AC-EC2DC6799122

P577

Q33814549-AB1425BB-F5F7-4212-8D96-CCDCE55BDA58

P5875

Q33814549-6BB81D63-A814-43A5-A247-4CE3F8923CCA

P698

Q33814549-1BF37799-4395-48EF-BB62-29011D3AA62B

P356

P1433

Annals of Pharmacotherapy

P1476

Candesartan cilexetil: an angiotensin II receptor blocker.

@en

P2093

A F Kaul

http://www.w3.org/2001/XMLSchema#string

C A Stoukides

http://www.w3.org/2001/XMLSchema#string

H J McVoy

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril.

A conditionally immortalized cell line from murine proximal tubule.

CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.

Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man

Inhibitory effects of candesartan on responses to angiotensin peptides in the hindquarters vascular bed of the cat.

Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension--a population analysis.

Mechanisms by which the Hawksley random zero sphygmomanometer underestimates blood pressure and produces a non-random distribution of RZ values.

P304

1287-1298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.19005

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12683180

http://www.w3.org/2001/XMLSchema#string

P698

10630830

http://www.w3.org/2001/XMLSchema#string